Correction to: Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Författaruppgift saknas
Am J Health Syst Pharm · published erratum · DOI 10.1093/ajhp/zxad325 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för xacduro. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
16 hits<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals.
Iovleva A, McElheny CL, Fowler EL, Cober E, Herc ES, Arias CA, Hill C, Baum K, Fowler VG, Chambers HF, Greenwood-Quaintance KE, Patel R, van Duin D, Bonomo RA, Doi Y.
Antimicrob Agents Chemother · brief-report; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.01258-23Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Ruiz VH, Shen Y, Abouelhassan Y, Fouad A, Nicolau DP, Kuti JL.
Am J Health Syst Pharm · research support, non-u.s. gov't; journal article · DOI 10.1093/ajhp/zxad232Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant <i>Acinetobacter baumannii</i> Infections - A Systematic Review.
Velmurugan H, Venkatesan S, Meles HN, Neelambaram K, Thangaraju P.
Infect Disord Drug Targets · systematic review; journal article · DOI 10.2174/0118715265276432231217192054Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests.
McLeod SM, Carter NM, Huband MD, Traczewski MM, Bradford PA, Miller AA.
J Clin Microbiol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/jcm.01228-23Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>.
Karruli A, Migliaccio A, Pournaras S, Durante-Mangoni E, Zarrilli R.
Antibiotics (Basel) · review-article; review; journal article · DOI 10.3390/antibiotics12121729<i>In vivo</i> dose response and efficacy of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against the <i>Acinetobacter baumannii-calcoaceticus</i> complex.
O'Donnell J, Tanudra A, Chen A, Newman J, McLeod SM, Tommasi R.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00800-23<b><i>I</i></b> <i>n vitro</i> pharmacokinetics/pharmacodynamics of the β-lactamase inhibitor, durlobactam, in combination with sulbactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex.
O'Donnell J, Tanudra A, Chen A, Miller AA, McLeod SM, Tommasi R.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00312-23Sulbactam/Durlobactam.
Beninger P.
Clin Ther · editorial · DOI 10.1016/j.clinthera.2023.11.009In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
Fouad A, Nicolau DP, Gill CM.
J Antimicrob Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/jac/dkad244Sulbactam/durlobactam (Xacduro) for Acinetobacter pneumonia.
Författaruppgift saknas
Med Lett Drugs Ther · journal article · DOI 10.58347/tml.2023.1690cMolecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of <i>Acinetobacter baumannii</i>.
Moussa SH, Shapiro AB, McLeod SM, Iyer R, Carter NM, Tsai Y-K, Siu LK, Miller AA.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00665-23Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections.
August B, Matlob A, Kale-Pradhan PB.
Ann Pharmacother · review; journal article · DOI 10.1177/10600280231204566Sulbactam/Durlobactam: First Approval.
Keam SJ.
Drugs · review; journal article · DOI 10.1007/s40265-023-01920-6Sulbactam and Durlobactam
Författaruppgift saknas
Journal missing · reviewSalvage therapy with sulbactam/durlobactam against cefiderocol-resistant <i>Acinetobacter baumannii</i> in a critically ill burn patient: clinical challenges and molecular characterization.
Tiseo G, Giordano C, Leonildi A, Riccardi N, Galfo V, Limongi F, Nicastro M, Barnini S, Falcone M.
JAC Antimicrob Resist · research-article; journal article · DOI 10.1093/jacamr/dlad078